Applied Therapeutics Inc
NASDAQ:APLT
Applied Therapeutics Inc
NASDAQ:APLT
Price:
0.103
USD
3%
Market Closed
Market Cap:
$15.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
ZACD Group Ltd
HKEX:8313
|
SG |
|
Banco do Brasil SA
F:BZLA
|
BR |
|
L
|
Linius Technologies Ltd
OTC:LNNTF
|
AU |
|
S
|
SECURE Inc
TSE:4264
|
JP |
|
Broendbyernes IF Fodbold A/S
CSE:BIF
|
DK |
|
C
|
CSL Ltd
SWB:CSJ
|
AU |
|
Novavax Inc
NASDAQ:NVAX
|
US |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
FSA Group Ltd
ASX:FSA
|
AU |
|
Miyakoshi Holdings Inc
TSE:6620
|
JP |
|
Neogen Corp
NASDAQ:NEOG
|
US |
|
Volex PLC
LSE:VLX
|
UK |
|
W
|
Washington Real Estate Investment Trust
F:WRI
|
US |
|
T
|
TG Metals Ltd
ASX:TG6
|
AU |
|
Able Engineering Holdings Ltd
HKEX:1627
|
HK |
|
G
|
GlobalBlock Digital Asset Trading Ltd
XTSX:BLOK
|
CA |
|
S
|
SaltX Technology Holding AB (publ)
STO:SALT B
|
SE |
|
H
|
Hangzhou Yitong New Materials Co Ltd
SZSE:300930
|
CN |
|
C
|
China Tobacco International HK Co Ltd
HKEX:6055
|
HK |
|
AES Brasil Energia SA
BOVESPA:AESB3
|
BR |
|
Radian Group Inc
NYSE:RDN
|
US |
|
Hangzhou Freely Communication Co Ltd
SSE:603602
|
CN |
|
Firstsource Solutions Ltd
NSE:FSL
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
APLT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.103 USD,
Applied Therapeutics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APLT Multiples-Based Value
LOCKED
Multiples Across Competitors
APLT Competitors Multiples
Applied Therapeutics Inc Competitors
Applied Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Applied Therapeutics Inc
NASDAQ:APLT
|
14.9m USD | 14.9 | -0.8 | -0 | -0 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
